Collaborative Mental Health Care Model: an Evaluation of the Implementation of a Pilot in Four Primary Care Organization (Mosaique)

Collaborative Mental Health Care Model: an Evaluation of the Implementation of a Pilot in Four Health Homes

Frequent mental disorders (anxiety or mood disorders), an important part of primary care patient care, remain insufficiently detected and treated. Improving their care requires better coordination between general practice and specialized care. The collaborative care model developed in Washington State with the introduction of a care manager is recognized. About 100 randomized controlled trials have established its effectiveness and efficiency, in terms of improving the progression of disorders (remission rate), adherence, quality of life, professional and patient satisfaction, and cost savings. However, the possibility of implementation of these validated care remains to be explored. A dozen collaborative care implementation studies exist, all conducted in the USA and not having considered all the dimensions of the indicators of penetration, acceptability/adoption, feasibility, fidelity and cost. A first implementation in France is implemented since September 2021 in the Yvelines department on four sites of different size, organization and environments: the multi-professional health centers (MSP) of Mureaux and Celle St Cloud, the Chevreuse medical house and MG in isolated practice in Versailles.

The main objective of the research project is to evaluate the first implementation in France of collaborative care for frequent psychic disorders according to the indicators of penetration, acceptability/adoption, fidelity, relevance, feasibility and cost.

Study Overview

• Status: Recruiting
• Conditions: Psychological Disorder
• Intervention / Treatment: Other: collaborative cares

• Study Type: Interventional
• Enrollment (Anticipated): 1200
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: nadia Younes; Phone Number: 01 39 63 83 12; Email: nyounes@ch-versailles.fr

Study Locations

• France
  • Chevreuse, France, 78460
    • Recruiting
    • Maison de Santé Pluridisciplinaire
    • Contact: Marie Anne Duval-Cattaneo
  • Versailles, France, 78000
    • Recruiting
    • Cabinet Médical Versailles
    • Contact: laurent de bastard
  • Versailles, France, 78000
    • Not yet recruiting
    • Cabinet Médical Versailles
    • Contact: jerome barre
  • les Mureaux, France, 78130
    • Recruiting
    • Maison de Santé Pluridisciplinaire
    • Contact: marie Hélène certain

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• healthcare professionals involved in the collaborative care system
• patients who have been referred for collaborative care by their family physician

Exclusion Criteria:

• patient refusal to participate in research
• adults protected by law

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: group experimental	Other: collaborative cares; coordinate care between city medicine and specialized psychiatric care to improve the management of common mental disorders

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
to evaluate the first implementation in France of collaborative care for frequent psychic disorders	numbers of patients and medical caregivers who participate in collaborative care	36 months

Collaborators and Investigators

• Sponsor: Dr Nadia YOUNES

Study record dates

Study Major Dates

• Study Start (Actual): July 13, 2022
• Primary Completion (Anticipated): May 1, 2024
• Study Completion (Anticipated): May 1, 2025

Study Registration Dates

• First Submitted: May 12, 2022
• First Submitted That Met QC Criteria: May 18, 2022
• First Posted (Actual): May 23, 2022

Study Record Updates

• Last Update Posted (Actual): August 25, 2022
• Last Update Submitted That Met QC Criteria: August 22, 2022
• Last Verified: August 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders
• Other Study ID Numbers: P21/10_mosaïque

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No